Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abemaciclib in Recurrent/Metastatic HNSCC (TRIUMPH Arm 4)
NCT03356587Phase 2Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2017
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
A Phase 2 trial of abemaciclib in head and neck squamous cell carcinoma (HNSCC), sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
abemaciclib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT03356587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03356587.